During the past decade, Hospital Santa Marcelina conducted 33 clinical trials. In the 10-year time frame, 33 clinical trials started and 16 clinical trials were completed, i.e. on average, 48.5% percent of trials that started reached the finish line to date. In the past 5 years, 14 clinical trials started and 13 clinical trials were completed. i.e. 92.9% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hospital Santa Marcelina" #1 sponsor was "Eurofarma Laboratorios S.A." with 8 trials, followed by "Takeda" with 5 trials sponsored, "Hoffmann-La Roche" with 4 trials sponsored, "Federal University of São Paulo" with 3 trials sponsored and "Amgen" with 3 trials sponsored. Other sponsors include 33 different institutions and companies that sponsored additional 38 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital Santa Marcelina" #1 collaborator was "Brazilian Research In Intensive Care Network" with 2 trials as a collaborator, "EMS" with 2 trials as a collaborator, "Hospital Sirio-Libanes" with 2 trials as a collaborator, "AbbVie" with 1 trials as a collaborator and "Bristol-Myers Squibb" with 1 trials as a collaborator. Other collaborators include 10 different institutions and companies that were collaborators in the rest 20 trials.

According to Clinical.Site data, the most researched conditions in "Hospital Santa Marcelina" are "Coronary Artery Disease" (5 trials), "Sickle Cell Disease" (3 trials), "Adenocarcinoma" (2 trials), "Chemotherapy-induced Thrombocytopenia" (2 trials) and "Coronavirus Infections" (2 trials). Many other conditions were trialed in "Hospital Santa Marcelina" in a lesser frequency.

Most popular intervention types in "Hospital Santa Marcelina" are "Drug" (45 trials), "Device" (6 trials), "Biological" (4 trials), "Other" (3 trials) and "Procedure" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (13 trials), "Carboplatin" (3 trials), "Cisplatin" (3 trials), "Nimotuzumab" (3 trials) and "Paclitaxel" (3 trials). Other intervention names were less common.

The vast majority of trials in "Hospital Santa Marcelina" are 54 trials for "All" genders, 4 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Hospital Santa Marcelina". undefined are not yet recruiting, 10 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 28 completed trials in Hospital Santa Marcelina, undefined suspended trials, and 7 terminated clinical trials to date.

Out of the total trials that were conducted in Hospital Santa Marcelina, 5 "Phase 1" clinical trials were conducted, 15 "Phase 2" clinical trials and 32 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 6 trials, and there were also 4 trials that are defined as “Not Applicable".

Hospital Santa Marcelina has several departments that took part in Clinical trials: "Hospital Santa Marcelina;Oncologia" - 4 trials